These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31745330)

  • 1. Antibiotic development - economic, regulatory and societal challenges.
    Årdal C; Balasegaram M; Laxminarayan R; McAdams D; Outterson K; Rex JH; Sumpradit N
    Nat Rev Microbiol; 2020 May; 18(5):267-274. PubMed ID: 31745330
    [No Abstract]   [Full Text] [Related]  

  • 2. What are the economic barriers of antibiotic R&D and how can we overcome them?
    Renwick M; Mossialos E
    Expert Opin Drug Discov; 2018 Oct; 13(10):889-892. PubMed ID: 30175625
    [No Abstract]   [Full Text] [Related]  

  • 3. Resisting antimicrobial resistance.
    Nathan C
    Nat Rev Microbiol; 2020 May; 18(5):259-260. PubMed ID: 32300248
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic research and development: business as usual?
    Harbarth S; Theuretzbacher U; Hackett J;
    J Antimicrob Chemother; 2015; 70(6):1604-7. PubMed ID: 25673635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Basis of Anesthesia: How to Overcome Stagnation?
    Kissin I; Vlassakov KV
    Anesth Analg; 2018 Nov; 127(5):1268-1270. PubMed ID: 29683831
    [No Abstract]   [Full Text] [Related]  

  • 6. The Global Antibiotic Research and Development Partnership (GARDP): a not-for-profit antibiotic development organisation.
    Piddock LJ;
    Lancet Infect Dis; 2018 Dec; 18(12):1304-1305. PubMed ID: 30420229
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of new antibacterials: a laudable aim, but what is the value?
    Tillotson GS
    Clin Infect Dis; 2010 Sep; 51(6):752-3; author reply 754-5. PubMed ID: 20731567
    [No Abstract]   [Full Text] [Related]  

  • 8. Overcoming the current deadlock in antibiotic research.
    Schäberle TF; Hack IM
    Trends Microbiol; 2014 Apr; 22(4):165-7. PubMed ID: 24698433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.
    Burgess DS; Slain D; Mohr J; Wong-Beringer A; Destache C; Suda K
    Clin Infect Dis; 2010 Sep; 51(6):753; author reply 754-5. PubMed ID: 20731568
    [No Abstract]   [Full Text] [Related]  

  • 10. Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board.
    Spellberg B; Nielsen TB; Gilbert DN; Shorr AF; Brass EP
    Ann Intern Med; 2019 Oct; 171(8):580-582. PubMed ID: 31590184
    [No Abstract]   [Full Text] [Related]  

  • 11. (Inter)nationalising the antibiotic research and development pipeline.
    Singer AC; Kirchhelle C; Roberts AP
    Lancet Infect Dis; 2020 Feb; 20(2):e54-e62. PubMed ID: 31753765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial resistance: is there a way out of the woods?
    Marra A
    Future Microbiol; 2011 Jul; 6(7):707-9. PubMed ID: 21797683
    [No Abstract]   [Full Text] [Related]  

  • 13. A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics.
    Renwick MJ; Brogan DM; Mossialos E
    J Antibiot (Tokyo); 2016 Feb; 69(2):73-88. PubMed ID: 26464014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Together towards a common goal: REVIVE, a community of antimicrobial researchers brought together by the Global Antibiotic Research & Development Partnership (GARDP).
    Pentz-Murr A; Piddock LJV
    J Antimicrob Chemother; 2019 Jul; 74(7):1769-1770. PubMed ID: 30793751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of antimicrobial resistance: What economics can contribute.
    Roope LSJ; Smith RD; Pouwels KB; Buchanan J; Abel L; Eibich P; Butler CC; Tan PS; Walker AS; Robotham JV; Wordsworth S
    Science; 2019 Apr; 364(6435):. PubMed ID: 30948524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The drug push.
    Servick K
    Science; 2015 May; 348(6237):850-3. PubMed ID: 25999488
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibacterial drug discovery in the resistance era.
    Brown ED; Wright GD
    Nature; 2016 Jan; 529(7586):336-43. PubMed ID: 26791724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A call for antibiotic alternatives research.
    Stanton TB
    Trends Microbiol; 2013 Mar; 21(3):111-3. PubMed ID: 23473628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antibiotic development hailed as game changing.
    Kirby T
    Lancet Infect Dis; 2015 Mar; 15(3):271-2. PubMed ID: 25749231
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotic resistance is ancient: implications for drug discovery.
    Wright GD; Poinar H
    Trends Microbiol; 2012 Apr; 20(4):157-9. PubMed ID: 22284896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.